Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Neuronetics, Inc.STIM · Entity 6248 | Vice President and CFO | May 13, 2019 | May 14, 2019 |
| Zomedica Corp.ZOM · Entity 6884 | Chief Financial Officer | June 10, 2024 | June 11, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Neuronetics, Inc.
Report date May 13, 2019 · Filed May 14, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,987 |
Ending reported balance
After 2019-05-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-05-13 · Sale · Disposed 563 · Balance 29,019 Row 2 · 2019-05-14 · Sale · Disposed 8,032 · Balance 20,987 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.445 to $15.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.445 to $15.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Zomedica Corp.
Report date June 10, 2024 · Filed June 11, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, without par valueSEC Table I · non-derivative | Direct | 25,000 |
Reported balance
After 2024-06-10 transaction · row 1
1 source rowRow 1 · 2024-06-10 · Purchase · Acquired 25,000 · Balance 25,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2024 Filed Jun 11, 2024 20:15 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 25,000 | $0.15 | $3,797.50 |
DisclosureSEC source: 0001654954-24-007615 · section16.xml · nonDerivative · entry 1 Donato Peter · CIK 0001408320 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:35 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantOptions to Buy Common Stock · Derivative | 2,500,000 | $0.00 Strike: $0.14 | $0.00 |
DisclosureSEC source: 0001654954-24-006419 · section16.xml · derivative · entry 1 Donato Peter · CIK 0001408320 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500,000 Underlying: Common Stock · 2,500,000 shares Expires 2024-05-13 F1 · derivative.exercise_date: The stock options vest annually in four equal installments commencing on May 13, 2025. Read SEC document |
| March 16, 2023 Filed Mar 20, 2023 21:24 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantOption to Buy Common Stock · Derivative | 5,000,000 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001654954-23-003193 · primary_doc.xml · derivative · entry 1 Donato Peter · CIK 0001408320 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 5,000,000 shares Expires 2023-03-16 F1 · derivative.exercise_date: The stock options vest annually in four equal installments commencing on March 16, 2024. Read SEC document |
| May 14, 2019 Filed May 14, 2019 17:49 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 8,032 | $14.90 | $119,676.80 |
DisclosureSEC source: 0001209191-19-029741 · doc4.xml · nonDerivative · entry 2 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,987 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.445 to $15.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 13, 2019 Filed May 14, 2019 17:49 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 563 | $15.40 | $8,670.20 |
DisclosureSEC source: 0001209191-19-029741 · doc4.xml · nonDerivative · entry 1 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,019 Read SEC document |
| May 10, 2019 Filed May 13, 2019 18:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 706 | $15.30 | $10,801.80 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 6 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,582 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.02 to $15.435 inclusive. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 24,051 | $0.00 Strike: $3.19 | $0.00 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · derivative · entry 9 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,662 Underlying: Common Stock · 24,051 shares Expires 2027-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on April 10 ,2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,672 | $0.00 Strike: $4.64 | $0.00 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · derivative · entry 8 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,014 Underlying: Common Stock · 7,672 shares Expires 2028-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on March 16, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,905 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · derivative · entry 7 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,667 Underlying: Common Stock · 6,905 shares Expires 2027-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on July 20, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 1,878 | $15.67 | $29,428.26 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 5 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,288 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.50 to $15.935 inclusive. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 20,469 | $15.23 | $311,742.87 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 4 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,166 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.50 to $15.4925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionCommon Stock | 24,051 | $3.19 | $76,722.69 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 3 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionCommon Stock | 7,672 | $4.64 | $35,598.08 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 2 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionCommon Stock | 6,905 | $2.32 | $16,019.60 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 1 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 19:11 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantEmployee Stock Option (right to buy) · Derivative | 24,652 | $0.00 Strike: $16.42 | $0.00 |
DisclosureSEC source: 0001209191-19-018606 · doc4.xml · derivative · entry 8 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,652 Underlying: Common Stock · 24,652 shares Expires 2029-03-08 F6 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on March 8, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 19:11 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,177 | $0.00 Strike: $3.19 | $0.00 |
DisclosureSEC source: 0001209191-19-018606 · doc4.xml · derivative · entry 7 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,713 Underlying: Common Stock · 8,177 shares Expires 2027-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on April 10 ,2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 19:11 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 14,007 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018606 · doc4.xml · nonDerivative · entry 5 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,007 F3 · shares: Twenty-five percent (25%) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of March 8, 2020 and March 8, 2021, and fifty percent (50%) of the shares subject to the RSU grant shall vest on March 8, 2022, subject to Reporting Person continuing to provide service through each such date. F4 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 19:11 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 8,177 | $16.01 | $130,913.77 |
DisclosureSEC source: 0001209191-19-018606 · doc4.xml · nonDerivative · entry 4 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.085 inclusive. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 19:11 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionCommon Stock | 8,177 | $3.19 | $26,084.63 |
DisclosureSEC source: 0001209191-19-018606 · doc4.xml · nonDerivative · entry 3 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 19:11 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 18,061 | $0.00 Strike: $3.19 | $0.00 |
DisclosureSEC source: 0001209191-19-018606 · doc4.xml · derivative · entry 6 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,890 Underlying: Common Stock · 18,061 shares Expires 2027-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on April 10 ,2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 19:11 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 18,061 | $16.21 | $292,768.81 |
DisclosureSEC source: 0001209191-19-018606 · doc4.xml · nonDerivative · entry 2 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.525 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 19:11 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionCommon Stock | 18,061 | $3.19 | $57,614.59 |
DisclosureSEC source: 0001209191-19-018606 · doc4.xml · nonDerivative · entry 1 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.